Dae Ho Lee

621 total citations · 1 hit paper
6 papers, 182 citations indexed

About

Dae Ho Lee is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Dae Ho Lee has authored 6 papers receiving a total of 182 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 3 papers in Oncology and 2 papers in Surgery. Recurrent topics in Dae Ho Lee's work include Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (1 paper) and Cancer therapeutics and mechanisms (1 paper). Dae Ho Lee is often cited by papers focused on Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (1 paper) and Cancer therapeutics and mechanisms (1 paper). Dae Ho Lee collaborates with scholars based in South Korea, United States and United Kingdom. Dae Ho Lee's co-authors include Ticiana Leal, Raffaele Califano, Bilal Piperdi, Martin Reck, Perran Fulden Yumuk, Lu Xu, Balazs Medgyasszay, Olivier Molinier, Adrian Langleben and Ayman Samkari and has published in prestigious journals such as Journal of Clinical Oncology, ESMO Open and Annals of Surgical Treatment and Research.

In The Last Decade

Dae Ho Lee

5 papers receiving 182 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study

2021 165 citations Michael Boyer, Mehmet Alı Nahıt Şendur et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Dae Ho Lee

Since Specialization

Citations

This map shows the geographic impact of Dae Ho Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dae Ho Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dae Ho Lee more than expected).

Fields of papers citing papers by Dae Ho Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dae Ho Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dae Ho Lee. The network helps show where Dae Ho Lee may publish in the future.

Co-authorship network of co-authors of Dae Ho Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Dae Ho Lee. A scholar is included among the top collaborators of Dae Ho Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dae Ho Lee. Dae Ho Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study 2024 ·ESMO Open ·(unknown), (unknown), (unknown), Youngjoo Lee, Dae Ho Lee, Sokbom Kang	6
2	Krascendo-170 Lung: A phase Ib/II study of divarasib + pembrolizumab ± platinum-based chemotherapy and pemetrexed in untreated KRAS G12C+advanced non-small cell lung cancer (NSCLC). 2024 ·Journal of Clinical Oncology ·Ferdinandos Skoulidis, Kristof Cuppens, Adrian G. Sacher, Vamsidhar Velcheti, Dae Ho Lee, Mark T. Lin, Tharu M. Fernando, Shuai Li, Denise Bradley, (unknown), Michael S. Mathisen	6
3	Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study breakdown → 2021 ·Journal of Clinical Oncology ·Michael Boyer, Mehmet Alı Nahıt Şendur, Delvys Rodríguez‐Abreu, Keunchil Park, Dae Ho Lee, İrfan Çiçin, Perran Fulden Yumuk, Francesco Orlandi, Ticiana Leal, Olivier Molinier, Nopadol Soparattanapaisarn, Adrian Langleben, Raffaele Califano, Balazs Medgyasszay, Te‐Chun Hsia, Gregory A. Otterson, Lu Xu, Bilal Piperdi, Ayman Samkari, Martin Reck, (unknown)	165
4	Meta-analysis of transanal versus laparoscopic total mesorectal excision for rectal cancer: a ‘New Health Technology’ assessment in South Korea 2021 ·Annals of Surgical Treatment and Research ·Sun‐Ho Kwon, (unknown), Seon Hahn Kim, Dae Ho Lee, Jeong‐Heum Baek, Soon Sup Chung, Ji-Yeon Shin, Chang Soo Eun, Nam Kyu Kim	4
5	Multidisciplinary care service: issues raised so far and possible solutions suggested 2016 ·Journal of Korean Medical Association ·Dae Ho Lee	1
6	After designation of Research-driven Hospitals 2014 ·Journal of Korean Medical Association ·Dae Ho Lee	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact